Ruinan Lu
About
In The Last Decade
Ruinan Lu
29 papers receiving 352 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 120
- Immunology 94
- Genetics 75
- Hematology 68
- Genetics 48
Countries citing papers authored by Ruinan Lu
This map shows the geographic impact of Ruinan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruinan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruinan Lu more than expected).
Fields of papers citing papers by Ruinan Lu
This network shows the impact of papers produced by Ruinan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruinan Lu. The network helps show where Ruinan Lu may publish in the future.
Co-authorship network of co-authors of Ruinan Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Ruinan Lu. A scholar is included among the top collaborators of Ruinan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruinan Lu. Ruinan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | 20 | |
| 7 | P27 deletion enhances hematopoiesis by paracrine action of IL22 secreted from bone marrow mesenchymal stem cells. | 2 |
| 8 | 22 | |
| 9 | 9 | |
| 10 | 8 | |
| 11 | 46 | |
| 12 | 18 | |
| 13 | 5 | |
| 14 | 13 | |
| 15 | 4 | |
| 16 | 1 | |
| 17 | 40 | |
| 18 | 20 | |
| 19 | 11 | |
| 20 | [Expression of P27(Kip1) and its clinical significance in acute and chronic leukemia]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.